DeepCyte

Headquartered in Delaware and Copenhagen, DeepCyte is on a mission to revolutionize toxicology. DeepCyte combines MetaCore—a category-defining high-throughput single-cell metabolomics platform—with DeeImmuno—an AI-driven toxicology solution—enabling biopharmaceutical teams to predict toxicity earlier, infer mechanisms, and move beyond animal models and large-scale testing toward human-centered drug safety assessment.